🇺🇸 FDA
Patent

US 10993941

Methods for the administration of certain VMAT2 inhibitors

granted A61KA61K31/4745A61K9/20

Quick answer

US patent 10993941 (Methods for the administration of certain VMAT2 inhibitors) held by Neurocrine Biosciences, Inc. expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/4745, A61K9/20, A61K9/48